Aurinia announces Brinda Balakrishnan to its board
She is Group Vice President, Corporate and Business Development of BioMarin Pharmaceutical Inc., a global biotechnology company that develops and commercializes innovative therapies for patients with serious and life-threatening rare disorders





































